PharmaShots | Incisive News in 3 Shots

Subscribe Now

Initiates

TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic Leukemia

TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic...

April 22, 2021

Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan

Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan

April 12, 2021

Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug

Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug

April 9, 2021

Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases

Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases

March 26, 2021

Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

March 26, 2021

GSK Initiates P-III Study of GSK3511294 (GSK'294) for the Treatment of Severe Asthma

GSK Initiates P-III Study of GSK3511294 (GSK'294) for the Treatment of Severe Asthma

March 18, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us